DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Active ingredient: Clidinium - Brands, Medical Use, Clinical Data

Brands, Medical Use, Clinical Data

Drug Category

  • Antiarrhythmic Agents
  • Anticholinergic Agents
  • Antispasmodics
  • Parasympatholytics

Dosage Forms

  • Capsules (2.5, 5 mg)

Brands / Synonyms

Chlordiazepoxide and Clidinium; Quarzan

Indications

For the treatment of peptic ulcer disease and also to help relieve abdominal or stomach spasms or cramps due to colicky abdominal pain, diverticulitis, and irritable bowel syndrome.

Pharmacology

Clidinium is a synthetic anticholinergic agent which has been shown in experimental and clinical studies to have a pronounced antispasmodic and antisecretory effect on the gastrointestinal tract.

Mechanism of Action

Inhibits muscarinic actions of acetylcholine at postganglionic parasympathetic neuroeffector sites.

Absorption

Not Available

Toxicity

Signs of toxicity include confusion, paralytic ileus, urinary hesitancy/retention, and blurred vision.

Biotrnasformation / Drug Metabolism

Not Available

Contraindications

Hypersensitivity to anticholinergic agents, narrow-angle glaucoma, GI obstruction, myasthenia gravis, paralytic ileus, GI atony, toxic megacolon.

Drug Interactions

Amantadine, tricyclic antidepressants, and MAOIs may increase anticholinergic effect of clidinium. Clidinium may decrease the effect of phenothiazines, levodopa, and ketoconazole.

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012